Detalhe da pesquisa
1.
Dynamic profiling of immune microenvironment during anti-PD-1 immunotherapy for head and neck squamous cell carcinoma: the IPRICE study.
BMC Cancer
; 23(1): 1209, 2023 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38066522
2.
Efficacy of second-line chemotherapy or immune checkpoint inhibitors for patients with a prolonged objective response (≥ 6 months) after first-line therapy for recurrent or metastatic head and neck squamous cell carcinoma: a retrospective study.
BMC Cancer
; 23(1): 663, 2023 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37452287
3.
Systemic treatment of metastatic squamous cell carcinoma of the head and neck: proposal for management changes.
Curr Opin Oncol
; 33(3): 160-167, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33782359
4.
Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab.
Gut
; 69(3): 531-539, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31101691
5.
Predictive factors for early progression during induction chemotherapy and chemotherapy-free interval: analysis from PRODIGE 9 trial.
Br J Cancer
; 122(7): 957-962, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32015513
6.
Hidden intra-mandibular carcinoma cuniculatum appearing in a patient with metastatic prostate cancer: a case report.
BMC Oral Health
; 19(1): 54, 2019 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30953484
7.
Any place left for induction chemotherapy for locally advanced head and neck squamous cell carcinoma?
Anticancer Drugs
; 29(4): 287-294, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29420335
8.
Cetuximab-Carboplatin-5-Fluorouracil Regimen in Elderly Patients with Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma: A French Retrospective Survey.
Oncology
; 93(1): 11-17, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28423384
9.
Standard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trial.
Radiother Oncol
; 197: 110329, 2024 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768714
10.
A novel ΔNp63-dependent immune mechanism improves prognosis of HPV-related head and neck cancer.
Front Immunol
; 14: 1264093, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38022675
11.
The EXTREME Regimen Associating Cetuximab and Cisplatin Favors Head and Neck Cancer Cell Death and Immunogenicity with the Induction of an Anti-Cancer Immune Response.
Cells
; 11(18)2022 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36139440
12.
Identification of HMGA2 as a predictive biomarker of response to bintrafusp alfa in a phase 1 trial in patients with advanced triple-negative breast cancer.
Front Oncol
; 12: 981940, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36568239
13.
Expression of immune response biomarkers (PDL1, p16, CD3+ and CD8+ TILs) in recurrent head and neck squamous cell carcinoma within previously irradiated areas.
Oncol Rep
; 45(3): 1273-1283, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33432367
14.
Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma.
Cancers (Basel)
; 13(12)2021 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34207120
15.
Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60 Patients.
Front Oncol
; 11: 714551, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34778031
16.
Immunotherapy Breakthroughs in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Cancers (Basel)
; 12(9)2020 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32967162
17.
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-ß and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohort.
J Immunother Cancer
; 8(2)2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32641320
18.
Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trial.
J Immunother Cancer
; 7(1): 275, 2019 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31651359
19.
Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal Cancer: The UNICANCER PRODIGE18 Randomized Clinical Trial.
JAMA Oncol
; 5(1): 83-90, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30422156
20.
Prognostic factors of survival in head and neck cancer patients treated with surgery and postoperative radiation therapy.
Acta Otolaryngol
; 128(6): 706-12, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18568509